Search

How can we maximize the potential and production of potentially life-saving therapies?

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Dick Sundh, Head of Europe at Kite, explains what it takes to commercialize CAR T cell therapy.

Here we explore the challenges involved in ensuring CAR T cell therapies are delivered to patients safely and as quickly as possible.

More deaths in a cancer immunotherapy trial raise questions over CAR-T safety

Our infographic examines China's CAR T therapy development.

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Our latest news roundup reports on a cell therapy facility expansion in Princeton, a magnet to capture T cells, and more.

A review article examines the evolving strategies and safety outcomes with allogeneic CAR T cell therapy.